<DOC>
	<DOCNO>NCT00519623</DOCNO>
	<brief_summary>This study design evaluate pharmacokinetics/pharmacodynamics investigational basal insulin patch type 1 diabetes patient .</brief_summary>
	<brief_title>Transdermal Basal Insulin Patch Study Type 1 Diabetes</brief_title>
	<detailed_description>The study look patient meet follow criterion : - Duration type diabetes great equal 10 year - HbA1C le equal 9.0 % - C-peptide negative - Ages 18 - 65 , male female - Body Mass Index ( BMI ) 18.5 - 32 - Non-smoker - No advanced diabetes complication - Not pregnant breast feeding</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Duration type 1 diabetes great equal 10 year HbA1c less equal 9.0 % Cpeptide negative Ages 18 65 , male female BMI 18.5 32 Non smoker No advance diabetes complication Not pregnant breast feeding Arm leg rash , open wound , skin condition Psychiatric disorder Participation clinical research trial last 3 month Clinically significant acute illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>diabetes</keyword>
	<keyword>insulin</keyword>
	<keyword>blood sugar</keyword>
	<keyword>type 1 diabetes</keyword>
	<keyword>insulin dependent diabetes</keyword>
	<keyword>transdermal</keyword>
</DOC>